It’s not just about the science
3 May 2019 | By Alice Laures - GSK, Lisa Wysocki - GSK, Paul J Newby - GSK
Modernisation of microbiological test methods involves far more than just the science. As new systems and technologies become available it becomes increasingly important that potential users can identify not only the technical requirements, but also the business case. Here, Paul Newby, Alice Laures and Lisa Wysocki from GlaxoSmithKline discuss criteria…
